Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Eikon Therapeutics
company
About
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
- Hayward,California,United States
- 251 - 500
- http://www.eikontx.com
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $518M
- Industries
- Biotechnology,Health Care,Life Science,Medical
- Founded date
- Jan 1, 2019
- Number Of Employee
- 251 - 500
- Operating Status
- Active
- Legal Name
- Eikon Therapeutics, Inc.
Eikon Therapeutics is a biopharmaceutical company employing revolutionary technology at the interface of biology, engineering, and chemistry to discover novel treatments for life-threatening diseases. Eikon’s discovery platform is built on groundbreaking innovations from its founders (Nobel Prize, 2014), culminating in the creation of microscopes that enable real-time, molecular-resolution measurements of protein movement in living cells.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$666M
Eikon Therapeutics has raised a total of
$666M
in funding over 2 rounds. Their latest funding was raised on
Jan 6, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 6, 2022 | Series B | $518M | 18 | — | — | Detail |
| May 5, 2021 | Series A | $148M | 4 |
The Column Group
|
— | Detail |
| Jan 1, 2019 | Seed | — | 1 | — | — | Detail |
Investments
Number of Investments
Number of Lead Investments
4
0
Eikon Therapeutics has made 4 investments. Their most recent investment was on
Oct 19, 2018, when Dapper Labs raised $15M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Oct 19, 2018
Dapper Labs
|
Series A | $15M | Blockchain | — |
|
Mar 20, 2018
Dapper Labs
|
Series A | $12.85M | Blockchain | — |
|
Oct 4, 2017
Torch
|
Seed | $2.40M | Corporate Training | — |
|
Mar 14, 2014
Cruise
|
Seed | $4.30M | Artificial Intelligence | — |
Investors
Number of Lead Investors
Number of Investors
1
18
Eikon Therapeutics is funded by 18 investors.
Abu Dhabi Investment Authority
and AME Cloud Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Abu Dhabi Investment Authority
|
— | Series B |
AME Cloud Ventures
|
— | Series B |
Canada Pension Plan Investment Board
|
— | Series B |
E15 VC
|
— | Series B |
|
|
— | Series B |
|
|
— | Series B |
General Catalyst
|
— | Series B |
Harel Insurance Investments and Financial Services
|
— | Series B |
|
|
— | Series B |
Horizons Ventures
|
— | Series B |
Employee Profiles
Number of Employee Profiles
12
Eikon Therapeutics has 12 current employee profiles, including
Board member Fei-Fei Li
Board member
Board member
Board member
Executive
Board member
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
